Worldwide: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Why 2026 Medicare Advantage Performance Still Rises Or Falls On Core Clinical Interventions

The Landscape for Medicare Advantage (MA) quality, as we know is ever evolving, particularly in light of the just released Contract Year (CY) 2027 Proposed Rule.

United States Healthcare

AC

Ankura Consulting Group LLC

US-UK Pharmaceutical Pricing Deal: UK Agrees Increase In Amounts It Can Pay For Innovative Medicines And Reduction Of Rebate Rates

The UK and US governments have announced that they have reached an agreement on pharmaceutical pricing and tariffs.

United States Healthcare

AP

Arnold & Porter

FDA's Tobacco Civil Money Penalty Authority, Cont'd: Not Backing Down

A few months ago, we blogged about a Texas U.S. District Court's Wulferic ruling that FDA's civil monetary penalty (CMP) provision for tobacco products contained...

United States Healthcare

HP

Hyman, Phelps, & McNamara

CMS Releases The Proposed 2027 Medicare Advantage And Part D Rules

Last week, the Centers for Medicare & Medicaid Services (CMS) released its proposed Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (Proposed 2027 Rules).

United States Healthcare

M

Mintz

Virtual And Digital Health Digest

Worldwide Healthcare

AP

Arnold & Porter

Digital Health Technologies Use In Clinical Trials: Support From MAHA And Defined Expectations From FDA's Final Guidance

United States Healthcare

FL

Foley & Lardner

The Weekly Hill Update - December 01, 2025

United States Healthcare

B

BakerHostetler

No Doctor, No Problem: The Benefits Of Innovation Expanding OTC Drug Access

United States Healthcare

N

NERA

$285 Million FCA Trebled Damages Award Against Caremark Sparks Appeal

United States Healthcare

AP

Arnold & Porter

The 2026 OPPS Final Rule: Hospitals Now At A Decision Point Regarding Drug Acquisition Cost Survey

United States Healthcare

KG

K&L Gates LLP

New Medical Device And IVD Registration And Transparency Requirements To Apply In 2026

United States Healthcare

AP

Arnold & Porter

Financing And Exit Strategies In Life Sciences: Aligning Capital With Compliance And IP Value

United States Healthcare

DM

Duane Morris LLP

What 340B Hospitals Need To Know About CMS's CY 2026 OPPS Final Rule

United States Healthcare

PL

Polsinelli LLP

Congress Introduces Bill To Create National Biomanufacturing Center Of Excellence

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

AI Innovation Is Accelerating, But Oversight Is Fragmented: Why ADR Must Fill The Governance Gap

United States Litigation

J

JAMS

Importing Steel Into Mexico A Pillar Of Compliance For Suppliers Trading With Mexico

United States International

BG

Braumiller Law Group, PLLC

[PODCAST] Utilizing Co-Mediation - Bringing Together Multiple Perspectives To Reach Effective Settlements

United States Litigation

J

JAMS

The Changes To The English Arbitration Regime: What Parties To International Construction Disputes Need To Know

United States Litigation

J

JAMS

District Court Invalidates Patents For Bridge Cheating Detection Software Under § 101

United States IP

JM

Jeffer Mangels Butler & Mitchell LLP

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Life Sciences, Biotechnology & Nanotechnology

US-UK Pharmaceutical Pricing Deal: UK Agrees Increase In Amounts It Can Pay For Innovative Medicines And Reduction Of Rebate Rates

The UK and US governments have announced that they have reached an agreement on pharmaceutical pricing and tariffs.

United States Healthcare

AP

Arnold & Porter

UPC Holds CE Marking Approval Is Evidence Of Imminent Infringement And Starts The Clock Running Where Considering Any (Unreasonable) Delay In A PI Application

The UPC's Hamburg Local Division (LD) has granted a preliminary injunction (PI) preventing Lepu Medical Technology (Beijing) Co from offering, placing on the market or using...

United States IP

KL

Herbert Smith Freehills Kramer LLP

FDA's Tobacco Civil Money Penalty Authority, Cont'd: Not Backing Down

A few months ago, we blogged about a Texas U.S. District Court's Wulferic ruling that FDA's civil monetary penalty (CMP) provision for tobacco products contained...

United States Healthcare

HP

Hyman, Phelps, & McNamara

New Medical Device And IVD Registration And Transparency Requirements To Apply In 2026

United States Healthcare

AP

Arnold & Porter

California Regulators Move Toward Classifying All P,p'-Bisphenol Chemicals As Causing Reproductive Toxicity Under Proposition 65

United States Energy

SH

Shook, Hardy & Bacon

Financing And Exit Strategies In Life Sciences: Aligning Capital With Compliance And IP Value

United States Healthcare

DM

Duane Morris LLP

Sector Focus: AI-Driven Tech, Healthcare And Financial Services Lead Dealmaking

United States Finance

D

Dechert

Congress Introduces Bill To Create National Biomanufacturing Center Of Excellence

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

From Operations To Assets: Quantifying The ROI Of AI In Financial Due Diligence

United States Healthcare

AM

Alvarez & Marsal

See more

Food and Drugs Law

US-UK Pharmaceutical Pricing Deal: UK Agrees Increase In Amounts It Can Pay For Innovative Medicines And Reduction Of Rebate Rates

The UK and US governments have announced that they have reached an agreement on pharmaceutical pricing and tariffs.

United States Healthcare

AP

Arnold & Porter

UPC Holds CE Marking Approval Is Evidence Of Imminent Infringement And Starts The Clock Running Where Considering Any (Unreasonable) Delay In A PI Application

The UPC's Hamburg Local Division (LD) has granted a preliminary injunction (PI) preventing Lepu Medical Technology (Beijing) Co from offering, placing on the market or using...

United States IP

KL

Herbert Smith Freehills Kramer LLP

FDA's Tobacco Civil Money Penalty Authority, Cont'd: Not Backing Down

A few months ago, we blogged about a Texas U.S. District Court's Wulferic ruling that FDA's civil monetary penalty (CMP) provision for tobacco products contained...

United States Healthcare

HP

Hyman, Phelps, & McNamara

CMS Releases The Proposed 2027 Medicare Advantage And Part D Rules

United States Healthcare

M

Mintz

New York State Enacts Cash Acceptance Law

United States Finance

HK

Holland & Knight

European Commission Secures "Pay For Delay" Victory In Top EU Court Ruling

European Union Anti-trust

AO

A&O Shearman

The 2026 OPPS Final Rule: Hospitals Now At A Decision Point Regarding Drug Acquisition Cost Survey

United States Healthcare

KG

K&L Gates LLP

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 123

European Union Strategy

JD

Jones Day

California Regulators Move Toward Classifying All P,p'-Bisphenol Chemicals As Causing Reproductive Toxicity Under Proposition 65

United States Energy

SH

Shook, Hardy & Bacon

See more

Healthcare

Why 2026 Medicare Advantage Performance Still Rises Or Falls On Core Clinical Interventions

The Landscape for Medicare Advantage (MA) quality, as we know is ever evolving, particularly in light of the just released Contract Year (CY) 2027 Proposed Rule.

United States Healthcare

AC

Ankura Consulting Group LLC

US-UK Pharmaceutical Pricing Deal: UK Agrees Increase In Amounts It Can Pay For Innovative Medicines And Reduction Of Rebate Rates

The UK and US governments have announced that they have reached an agreement on pharmaceutical pricing and tariffs.

United States Healthcare

AP

Arnold & Porter

UPC Holds CE Marking Approval Is Evidence Of Imminent Infringement And Starts The Clock Running Where Considering Any (Unreasonable) Delay In A PI Application

The UPC's Hamburg Local Division (LD) has granted a preliminary injunction (PI) preventing Lepu Medical Technology (Beijing) Co from offering, placing on the market or using...

United States IP

KL

Herbert Smith Freehills Kramer LLP

CMS Releases The Proposed 2027 Medicare Advantage And Part D Rules

United States Healthcare

M

Mintz

Virtual And Digital Health Digest

Worldwide Healthcare

AP

Arnold & Porter

Digital Health Technologies Use In Clinical Trials: Support From MAHA And Defined Expectations From FDA's Final Guidance

United States Healthcare

FL

Foley & Lardner

The Weekly Hill Update - December 01, 2025

United States Healthcare

B

BakerHostetler

Illinois Becomes The First State To Regulate The Use Of AI Mental Health Therapy Services

United States Technology

SM

Sheppard Mullin Richter & Hampton

No Doctor, No Problem: The Benefits Of Innovation Expanding OTC Drug Access

United States Healthcare

N

NERA

See more

Latest Videos

See more

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Ready To Deal: What Healthcare Providers Need To Know Before Raising Capital Or Selling (Video)

SM

Sheppard Mullin Richter & Hampton

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

Redefining Healthcare Leadership: Dr. Heather Farley On The Inaugural Role Of Chief Well-being Officer At MUSC (Video)

AM

Alvarez & Marsal

The Journey To Better Healthcare With Ben Kruger (Video)

OK

Offit Kurman

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More